Cytosorbents CTSO 深 沪
等待开盘 11-11 09:30:00 美东时间
6.01
+0.180
+3.09%
华盛通- 最 高6.115
- 今 开5.80
- 成交量 6856股
- 最 低 5.80
- 昨 收 5.83
- 总市值 1888.42万
- 52周最高 17.00
- 市盈率 静 --
- 换手率 0.22%
- 52周最低 2.8402
- 委 比 86.92%
- 总股本 314.21万
- 历史最高 304.80
- 量 比 0.49
- 振 幅 5.40%
- 历史最低 1.80
- 每 手 1
- 风险率 3.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cytosorbents Corporation收涨0.88%，成交额7.88万美元
11月6日，Cytosorbents Corporation（CTSO）收涨0.88%，报4.6美元，成交额7.88万美元，市值1449.54万美元。 行情数据...
11-06 08:56
Cytosorbents Corporation收跌16.03%，成交额23.43万美元
10月30日，Cytosorbents Corporation（CTSO）收跌16.03%，报4.4美元，成交额23.43万美元，市值1386.43万美元。 行...
10-30 07:53
Cytosorbents Corporation收涨12.34%，成交额41.96万美元
10月23日，Cytosorbents Corporation（CTSO）收涨12.34%，报6.01美元，成交额41.96万美元，市值1893.74万美元。...
10-23 07:50
美股大行评级 | 潜在涨幅227.21%！Jones Trading上调Rapport Therapeutics(RAPP)目标价至82美元，维持"买入"评级
今日重点评级关注：Jones Trading：维持Rapport Therapeutics"买入"评级，目标价从50美元升至82美元；摩根大通：维持SpaceX"超配"评级，目标价从240美元升至500美元
10-22 11:59
WBB Securities Initiates Coverage On CytoSorbents with Speculative Buy Rating, Announces Price Target of $9.5
WBB Securities analyst Karen Sterling initiates coverage on CytoSorbents (NASDAQ:CTSO) with a Speculative Buy rating and announces Price Target of $9.5.
10-22 00:15
Cytosorbents Corporation收涨34.31%，成交额282.24万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:59
CytoSorbents Regains Nasdaq Compliance, Pursues Growth Initiatives
Cytosorbents ( ($CTSO) ) has issued an update. On September 22, 2026, CytoSorbe...
09-23 19:57
CytoSorbents regains Nasdaq minimum bid price requirement compliance
CytoSorbents (CTSO) on Wednesday said it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement. On September 22, 2026, CytoSorbents received notification from Nasdaq tha...
09-23 19:23
CytoSorbents to execute 1:20 reverse stock split
CytoSorbents (CTSO) plans to implement a one-for-twenty reverse stock split, effective on September 8, 2026. The reverse stock split is intended to, among other things, increase the per-share trading ...
09-03 19:13
CytoSorbents Announces Reverse Stock Split
Reverse Stock Split Previously Approved by Shareholders; Intended to Support Compliance with Nasdaq's $1.00 Minimum Bid Price Requirement Expected to Become Effective and Trade on Split-Adju...
09-03 19:00
